Basic Information | Post buying leads | Suppliers |
Name |
Prulifloxacin [INN] |
EINECS | N/A |
CAS No. | 123447-63-2 | Density | 1.62 g/cm3 |
PSA | 134.43000 | LogP | 3.16270 |
Solubility | N/A | Melting Point |
N/A |
Formula | C21H20FN3O6S | Boiling Point | 633.2 °C at 760 mmHg |
Molecular Weight | 461.46 | Flash Point | 336.8 °C |
Transport Information | N/A | Appearance | N/A |
Safety | Risk Codes | N/A | |
Molecular Structure | Hazard Symbols | N/A | |
Synonyms |
Prulifloxacin; |
The Prulifloxacin [INN], with the CAS registry number of 123447-63-2, is also known as 6-Fluoro-1-methyl-7-(4-(5-methyl-2-oxo-1, 3-dioxelen-4-yl)methyl-1-piperazinyl)-4-oxo-4h-(1, 3)thiazeto(3, 2-a)quinoline-3-carboxylic acid. This chemical's molecular formula is C21H20FN3O6S and molecular weight is 461.46. What's more, its systematic name is called 6-Fluoro-1-methyl-7-{4-[(5-methyl-2-oxo-1, 3-dioxol-4-yl)methyl]piperazin-1-yl}-4-oxo-4H-[1, 3]thiazeto[3, 2-a]quinoline-3-carboxylic acid. Prulifloxacin [INN] is an older synthetic chemotherapeutic antibiotic of the fluoroquinolone drug class currently undergoing clinical trials prior to a possible NDA (New Drug Application) submission to the U.S. Food and Drug Administration (FDA). It is a prodrug which is metabolized in the body to the active compound ulifloxacin.
Physical properties about Prulifloxacin [INN] are: (1)ACD/LogP: 3.27; (2)# of Rule of 5 Violations: 0; (3)ACD/LogD (pH 5.5): 2.64; (4)ACD/LogD (pH 7.4): 1.47; (5)ACD/BCF (pH 5.5): 42.18; (6)ACD/BCF (pH 7.4): 2.86; (7)ACD/KOC (pH 5.5): 336.27; (8)ACD/KOC (pH 7.4): 22.81; (9)#H bond acceptors: 9; (10)#H bond donors: 1; (11)#Freely Rotating Bonds: 4; (12)Polar Surface Area: 113.92 Å2; (13)Index of Refraction: 1.72; (14)Molar Refractivity: 112.05 cm3; (15)Molar Volume: 283.5 cm3; (16)Surface Tension: 82 dyne/cm; (17)Density: 1.62 g/cm3; (18)Flash Point: 336.8 °C; (19)Enthalpy of Vaporization: 98.39 kJ/mol; (20)Boiling Point: 633.2 °C at 760 mmHg; (21)Vapour Pressure: 6.62E-17 mmHg at 25 °C.
Uses: it has been approved for the treatment of uncomplicated and complicated urinary tract infections, community-acquired respiratory tract infections in Italy and gastroenteritis, including infectious diarrheas, in Japan. Prulifloxacin [INN] has not been approved for use in the United States.
You can still convert the following datas into molecular structure:
(1) SMILES: O=C1O\C(=C(/O1)CN5CCN(c4cc2c(C(=O)\C(=C3\SC(N23)C)C(=O)O)cc4F)CC5)C
(2) InChI: InChI=1/C21H20FN3O6S/c1-10-16(31-21(29)30-10)9-23-3-5-24(6-4-23)15-8-14-12(7-13(15)22)18(26)17(20(27)28)19-25(14)11(2)32-19/h7-8,11H,3-6,9H2,1-2H3,(H,27,28)
(3) InChIKey: PWNMXPDKBYZCOO-UHFFFAOYAI